These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 11423973)
21. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. Portella G; Salvatore D; Botti G; Cerrato A; Zhang L; Mineo A; Chiappetta G; Santelli G; Pozzi L; Vecchio G; Fusco A; Santoro M Oncogene; 1996 Nov; 13(9):2021-6. PubMed ID: 8934550 [TBL] [Abstract][Full Text] [Related]
22. ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases. Carlomagno F; Vitagliano D; Guida T; Ciardiello F; Tortora G; Vecchio G; Ryan AJ; Fontanini G; Fusco A; Santoro M Cancer Res; 2002 Dec; 62(24):7284-90. PubMed ID: 12499271 [TBL] [Abstract][Full Text] [Related]
23. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Minoletti F; Butti MG; Coronelli S; Miozzo M; Sozzi G; Pilotti S; Tunnacliffe A; Pierotti MA; Bongarzone I Genes Chromosomes Cancer; 1994 Sep; 11(1):51-7. PubMed ID: 7529046 [TBL] [Abstract][Full Text] [Related]
24. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191 [TBL] [Abstract][Full Text] [Related]
25. [Rearrangement of the RET gene in papillary thyroid carcinoma]. Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064 [TBL] [Abstract][Full Text] [Related]
27. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1. Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763 [TBL] [Abstract][Full Text] [Related]
28. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523 [TBL] [Abstract][Full Text] [Related]
29. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese. Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154 [TBL] [Abstract][Full Text] [Related]
30. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas. Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668 [TBL] [Abstract][Full Text] [Related]
31. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093 [TBL] [Abstract][Full Text] [Related]
32. The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes. Carlomagno F; Vitagliano D; Guida T; Napolitano M; Vecchio G; Fusco A; Gazit A; Levitzki A; Santoro M Cancer Res; 2002 Feb; 62(4):1077-82. PubMed ID: 11861385 [TBL] [Abstract][Full Text] [Related]
33. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393 [TBL] [Abstract][Full Text] [Related]
34. [Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement]. Rabes HM; Klugbauer S Verh Dtsch Ges Pathol; 1997; 81():139-44. PubMed ID: 9474864 [TBL] [Abstract][Full Text] [Related]
35. Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers. Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B Endocrinology; 2008 Oct; 149(10):5107-17. PubMed ID: 18583418 [TBL] [Abstract][Full Text] [Related]
36. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? Mayr B; Brabant G; Goretzki P; Rüschoff J; Dietmaier W; Dralle H J Clin Endocrinol Metab; 1997 Apr; 82(4):1306-7. PubMed ID: 9100614 [No Abstract] [Full Text] [Related]
37. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis. Mizuno T; Kyoizumi S; Suzuki T; Iwamoto KS; Seyama T Oncogene; 1997 Sep; 15(12):1455-60. PubMed ID: 9333021 [TBL] [Abstract][Full Text] [Related]
38. A ret transgenic mouse model of thyroid carcinogenesis. Capen C; Sagartz J Lab Anim Sci; 1998 Dec; 48(6):580-3. PubMed ID: 10090080 [No Abstract] [Full Text] [Related]
39. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191 [TBL] [Abstract][Full Text] [Related]
40. A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM Oncogene; 1996 Sep; 13(5):1099-1102. PubMed ID: 8806700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]